Literature DB >> 9016823

Human hepatic microsomal epoxide hydrolase: comparative analysis of polymorphic expression.

C Hassett1, J Lin, C L Carty, E M Laurenzana, C J Omiecinski.   

Abstract

Interindividual variation in the expression of human microsomal epoxide hydrolase (mEH) may be an important risk factor for chemically induced toxicities, including cancer and teratogenesis. In this study, phenotypic variability and mEH genetic polymorphisms were examined in a bank of 40 transplant-quality human liver samples. Immunochemically determined protein content, enzymatic activities, polymorphic amino acids, as well as mEH RNA levels were evaluated in parallel. Enzymatic activity was assessed using (+/-)-benzo[a]pyrene-4,5-epoxide at 2 substrate concentrations. The relative hydrolyzing activities obtained using saturating substrate levels were highly correlated (r = 0.85) with results derived from limiting substrate concentrations and exhibit approximately an 8-fold range in activity levels across the panel of 40 liver samples. mEH enzyme activity also demonstrated strong correlation (r > or = 0.74) with an 8.4-fold variation determined for mEH protein content within the same samples. However, these protein/activity measurements were poorly correlated (r < or = 0.23) with mEH RNA levels, which exhibited a 49-fold variation. Two common polymorphic amino acid loci in the mEH protein did not exclusively account for variation in enzymatic activity, although this conclusion is confounded by heterozygousity in the samples. These data demonstrate the extent of hepatic mEH functional variability in well-preserved human tissues and suggest that polymorphism of mEH protein expression is regulated in part by posttranscriptional controls, which may include nonstructural regulatory regions of the mEH transcript.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9016823     DOI: 10.1006/abbi.1996.9794

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  26 in total

Review 1.  System review and metaanalysis of the relationships between five metabolic gene polymorphisms and colorectal adenoma risk.

Authors:  Zhi-Qiang Zhao; Qing-Kai Guan; Fei-Yun Yang; Peng Zhao; Bing Zhou; Zhi-Jun Chen
Journal:  Tumour Biol       Date:  2011-12-13

2.  Variability in human sensitivity to 1,3-butadiene: influence of polymorphisms in the 5'-flanking region of the microsomal epoxide hydrolase gene (EPHX1).

Authors:  Sherif Z Abdel-Rahman; Marinel M Ammenheuser; Curtis J Omiecinski; Jeffrey K Wickliffe; Judah I Rosenblatt; Jonathan B Ward
Journal:  Toxicol Sci       Date:  2005-02-16       Impact factor: 4.849

3.  The Association Between Epoxide Hydrolase Genetic Variant and Effectiveness of Nicotine Replacement Therapy in a Han Chinese Population.

Authors:  Fan Wang; Yanlong Liu; Song Guo; Dafang Chen; Hongqiang Sun
Journal:  Neurosci Bull       Date:  2016-10-25       Impact factor: 5.203

4.  In Vitro Metabolism of Oprozomib, an Oral Proteasome Inhibitor: Role of Epoxide Hydrolases and Cytochrome P450s.

Authors:  Zhican Wang; Ying Fang; Juli Teague; Hansen Wong; Christophe Morisseau; Bruce D Hammock; Dan A Rock; Zhengping Wang
Journal:  Drug Metab Dispos       Date:  2017-04-20       Impact factor: 3.922

5.  Polymorphisms in carcinogen metabolism enzymes, fish intake, and risk of prostate cancer.

Authors:  Chelsea Catsburg; Amit D Joshi; Román Corral; Juan Pablo Lewinger; Jocelyn Koo; Esther M John; Sue A Ingles; Mariana C Stern
Journal:  Carcinogenesis       Date:  2012-05-18       Impact factor: 4.944

6.  Stereoselective pharmacokinetics and pharmacodynamics of propylisopropyl acetamide, a CNS-active chiral amide analog of valproic acid.

Authors:  O Spiegelstein; B Yagen; R H Levy; R H Finnell; G D Bennett; M Roeder; V Schurig; M Bialer
Journal:  Pharm Res       Date:  1999-10       Impact factor: 4.200

7.  Is there a role for MDR1, EPHX1 and protein Z gene variants in modulation of warfarin dosage? a study on a cohort of the Egyptian population.

Authors:  Marianne Samir Makboul Issac; Maggie S El-Nahid; Marian Youssry Wissa
Journal:  Mol Diagn Ther       Date:  2014-02       Impact factor: 4.074

Review 8.  Pharmacogenetics of oral anticoagulants: a basis for dose individualization.

Authors:  Simone Stehle; Julia Kirchheiner; Andreas Lazar; Uwe Fuhr
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 9.  Microsomal epoxide hydrolase 1 (EPHX1): Gene, structure, function, and role in human disease.

Authors:  Radka Václavíková; David J Hughes; Pavel Souček
Journal:  Gene       Date:  2015-07-26       Impact factor: 3.688

10.  Alternative promoters determine tissue-specific expression profiles of the human microsomal epoxide hydrolase gene (EPHX1).

Authors:  Shun-Hsin Liang; Christopher Hassett; Curtis J Omiecinski
Journal:  Mol Pharmacol       Date:  2004-10-01       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.